Budget impact model of acellular tissue engineered vessel for the repair of extremity arterial trauma when autologous vein is not feasible by Fulton F. Velez (9600028)

“…</p> <p>With introduction of ATEV, there was a 29.8% reduction in amputations and a 29.5% reduction in graft infections over 3 years. …”

LNAME and TEMPOL restored α-actin and decreased MMPs at the BT of ligated animals. by Nicholas Liaw (592158)

“…<p>Smooth muscle α-actin, MMP-2 and MMP-9 proteins were detected by immunofluorescence in sham-operated animals (A, F, K), and in CCA ligated animals given no inhibitors (B, G, L), or treated with LNAME (C, H, M), or TEMPOL (D, I, N). α-actin staining in the media significantly decreased at the BT following ligation (B) compared to sham-operated animals (A), but was restored with either LNAME (C) or TEMPOL (D) treatment. …”

Descriptive statistics†. by Raimundo Atal (18272064)

“…Respondents were asked basic socioeconomic questions and a version of the EQ-5D-5L questionnaire that was used to calculate the evolution of HRQoLs. …”

Robustness of results. by Raimundo Atal (18272064)

“…Respondents were asked basic socioeconomic questions and a version of the EQ-5D-5L questionnaire that was used to calculate the evolution of HRQoLs. …”

Top 20 genes with increased and decreased expression in <i>Sdl</i> leukemias. by Bruce N. Bagley (123614)

RKIP inhibits local breast cancer invasion by decreasing MMP13 expression. by Ila Datar (433874)

“…<p>RKIP inhibits local breast cancer invasion by decreasing MMP13 expression. (a) Weights of primary tumors dissected from mice injected orthotopically with 4T1 cells stably infected with the indicated retroviral expression vectors. …”

Demographics and baseline characteristics of the safety population. by Rahsan Erdem (11726357)

Subjects:

iOWH032 inhibits cholera toxin-induced secretion in a mouse closed-loop model. by Rahsan Erdem (11726357)

Subjects:

Grading of stool consistency and diarrhea severity. by Rahsan Erdem (11726357)

Subjects:

Secondary efficacy endpoints for the modified intent-to-treat population. by Rahsan Erdem (11726357)

Subjects:

Study drug–related treatment-emergent adverse events by system organ class and preferred term in the safety population. by Rahsan Erdem (11726357)

Subjects:

Source data for Fig 1. by Rahsan Erdem (11726357)

Subjects:

Diarrheal stool output rate overall and by blood type status in the modified intent-to-treat population. by Rahsan Erdem (11726357)

Subjects:

Source data for S1 and S2 Figs. by Rahsan Erdem (11726357)

Subjects:

Source data for Fig 2. by Rahsan Erdem (11726357)

Subjects:

Consolidated Standards for Reporting of Trials flow diagram. by Rahsan Erdem (11726357)

Subjects:

iOWH032 inhibits cholera toxin-induced fecal output in a cecectomized rat model. by Rahsan Erdem (11726357)

Subjects:

Source data for Fig 3. by Rahsan Erdem (11726357)

Subjects:

Scatterplot of iOWH032 plasma concentrations versus diarrheal stool output rate. by Rahsan Erdem (11726357)

Subjects:

Reverse cumulative distribution plot for diarrheal stool output rate overall in the modified intent-to-treat population. by Rahsan Erdem (11726357)

Subjects: